436
Views
14
CrossRef citations to date
0
Altmetric
Original ArticlesIVF in Poor Responders

The comparision of effect of microdose GnRH-a flare-up, GnRH antagonist/aromatase inhibitor letrozole and GnRH antagonist/clomiphene citrate protocols on IVF outcomes in poor responder patients

, , , , , & show all
Pages 485-489 | Received 20 Jul 2013, Accepted 09 Feb 2014, Published online: 05 Mar 2014

References

  • Jenkins JM, Davies DW, Devonport H, et al. Comparison of ‘poor’ responders with ‘good’ responders using a standard buserelin/human menopausal gonadotrophin regime for in-vitro fertilization. Hum Reprod 1991;6:918–21
  • Ben-Rafael Z, Bider D, Dan U, et al. Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMG. J In Vitro Fert Embryo Transf 1991;8:33–6
  • Surrey ES, Bower J, Hill DM, et al. Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization. Fertil Steril 1998;69:419–24
  • Korhan Kahraman, Bulent Berker, Cem Somer Atabekoglu, et al. Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple döşe gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection–embryo transfer cycle. Fertility and Sterility 2009;91:2437–44
  • Detti L,Williams D, Robins J, et al. A comparison of three down regulation approaches for poor responders undergoing in vitro fertilization. Fertil Steril 2005;84:1401–5
  • William B. Schoolcraft, Eric S. Surrey, Debra A. Minjarez, et al. Management of poor responders: can outcomes be improved with a novel gonadotropin-releasing hormone antagonist/letrozole protocol?. Fertility and Sterility 2008;89:151–6
  • Mitwally M, Casper R. Using aromatase inhibitors to induce ovulation in breast Ca survivors. Contemp Ob Gyn 2004;49:73–84
  • Mitwally M, Casper R. Aromatase inhibition improves ovarian response to follicle stimulation hormone in poor responders. Fertil Steril 2002;77:776–80
  • Gibreel A, Maheshwari A, Bhattacharya S. Clomiphene citrate in combination with gonadotropins for controlled ovarian stimulation in women undergoing in vitro fertilization (Review). Cochrane Database Syst Rev 2012;11:CD008528
  • Ferraretti AP, La Marca A, Fauser BCJM, et al. on behalf of the ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of ‘poor response’ to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod 2011;26:1616–24
  • Pandian Z, McTavish AR, Aucott L, et al. Interventions for ‘poor responders’ to controlled ovarian hyper stimulation (COH) in in-vitro fertilisation (IVF) (Review). Cochrane Database Syst Rev. 2010;(1):CD004379
  • Scott RT, Navot D. Enhancement of ovarian responsiveness with microdoses of gonadotropin-releasing hormone agonist during ovulation induction for in vitro fertilization. Fertil Steril 1994;61:880–5
  • Akman M, Erden H, Tosun S, et al. Comparison of agonistic flare-up protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial. Hum Reprod 2001;16:868–70
  • Garcia-Velasco JA, Moreno L, Pacheco A, et al. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril 2005;84:82–7
  • Yarali H, Esinler I, Polat M, et al. Antagonist/letrozole protocol in poor ovarian responders for intracytoplasmic sperm injection: a comparative study with the microdose flare-up protocol. Fertil. Steril 2009;92:231–5
  • Davar R, Oskouian H, Ahmadi S, Firouzabadi R. GnRH antagonist/letrozole versus microdose GnRH agonist flare protocol in poor responders undergoing in vitro fertilization. Taiwan J Obstet Gynecol 2010;49:297–301
  • Vivian Chi Yan Lee, Carina Chi Wai Chan, Ernest Hung Yu Ng, et al. Sequential use of letrozole and gonadotrophin in women with poor ovarian reserve: a randomized controlled trial. Reprod Biomed Online 2011;23:380–8

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.